Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Ashiq Mubarack's Stock Ratings
Citigroup Analyst
Ashiq Mubarack is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/27/2025
Overall Average Return
-16.7%
Smart Score
Overall Average Return Percentile
15th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 08/27/2024 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 1274.76% | Ashiq Mubarack36% | $6 → $5 | Maintains | Buy | Get Alert |
| 12/15/2023 | DRTS | Buy Now | Alpha Tau Medical | $2.69 | 197.4% | Ashiq Mubarack36% | → $8 | Initiates | → Buy | Get Alert |
| 12/04/2023 | MRSN | Buy Now | Mersana Therapeutics | $0.36 | 1274.76% | Ashiq Mubarack36% | $1 → $5 | Upgrade | Neutral → Buy | Get Alert |
